Early Expert Observations on Medicare Part D

eAlert 86947ed7-6a16-4884-94a9-76512b82cef0

<p>The launch of the new Medicare Part D prescription drug benefit has been confusing for many beneficiaries, who often must choose among a dizzying array of plan options. And many states are now offering emergency prescription drug coverage for certain enrollees, raising questions about the program's ability to meet the needs of the population it serves, particularly low-income beneficiaries and individuals with chronic health conditions.<Br><br>In this month's <a href="/cnlib/pub/enews_clickthrough.htm?enews_item_id=20561&return_url=http%3A%2F%2Fwww%2Ecmwf%2Eorg%2Fspotlights%2Fspotlights%5Fshow%2Ehtm%3Fdoc%5Fid%3D342407%26%23doc342407">"In the Spotlight,"</a> Fund grantee Bruce Stuart, Ph.D., executive director of the Peter Lamy Center on Drug Therapy and Aging at the University of Maryland School of Pharmacy, shares his early observations regarding Part D, the kinds of challenges beneficiaries may face, and his Fund-supported effort to profile beneficiaries' medication use.</p>